Signaling Pathway
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 20305 | ONC201 HCl | 1638178-82-1 | 98% Min. |  |
| ONC-201, also known as TIC10 and imipridone, is a potent, orally active, and stable s | ||||
| 20306 | SRI-37330 HCl | 2322245-49-6 | ≧98.0% |  |
| SRI-37330 hydrochloride 是一种新型 TXNIP 表达抑制剂，呈剂量依赖性抑 | ||||
| 20314 | Obicetrapib | 866399-87-3 | 98% Min. |  |
| Obicetrapib (also known as AMG-899, TA-8995, and DEX-001) is a cholesteryl ester tran | ||||
| 20344 | SMN-C3 抑制剂 | 1449597-34-5 | ≧98.0% |  |
| SMN-C3 是一种口服活性 SMN2 剪接调节剂。可用于脊椎肌肉萎缩 (SMA) | ||||
| 20474 | Tinlarebant ( LBS-008 ) | 1821327-95-0 | ≧98.0% |  |
| Tinlarebant (LBS-008) 是一种视黄醇结合蛋白 4 (RBP4) 的小分子抑制剂。 | ||||
| 20517 | HM43239 | 2569527-64-4 | 98% Min. |  |
| HM43239 is an orally active small molecule inhibitor of FLT3 that selectively inhibit | ||||
| 20518 | BMS-986141 | 1478711-48-6 | 98% Min. |  |
| BMS-986141 is an Orally-Active Small-Molecule Antagonist of the Platelet Protease-Act | ||||
| 20519 | BMS-986120 | 1478712-37-6 | 98% Min. |  |
| BMS-986120 is a potent and selective oral antagonist of protease-activated receptor-4 | ||||
| 20577 | LY-3522348 | 2568608-48-8 | ≧98.0% |  |
| LY-3522348是一种酮己糖激酶（KHK）抑制剂. | ||||
| 20594 | JTE-151 | 1404380-58-0 | ≧98.0% |  |
| JTE-151 是一种 RORγ 抑制剂，可通过抑制与 Th17 细胞活化相关的 ROR | ||||
| 20618 | Pirtobrutinib | 2101700-15-4 | 98% Min. |  |
| 20650 | Sonrotoclax (BGB-11417) | 2383086-06-2 | ≧98.0% |  |
| Sonrotoclax is an antineoplastic. | ||||